Development of modern immunizing agent against porcine circovirus type 2 infection based on chimeric VP1-PCV2bCap recombinant protein
Alena Vrablikova(Veterinary Research Institute), Renata Héžová(Veterinary Research Institute), Veronika Brezáni(Beth Israel Deaconess Medical Center), Kristina Zechmeisterova, Pavel Kulich(Veterinary Research Institute), I. Pšikal(Veterinary Research Institute), Jan Kotouček(Veterinary Research Institute), Nicol Straková(Veterinary Research Institute), Eliška Mašková(University of Veterinary Sciences Brno), Adam Novobilský(Veterinary Research Institute), Martina Fojtíková(Veterinary Research Institute), Josef Mašek(Veterinary Research Institute), Jan M. Gebauer(University of Cologne), Martin Fraiberk(Charles University)
Cited by 0
Related Papers
Structure and Dynamics of Alginate Gels Cross-Linked by Polyvalent Ions Probed via Solid State NMR Spectroscopy
|Biomacromolecules|2017|201
Multi-layered nanofibrous mucoadhesive films for buccal and sublingual administration of drug-delivery and vaccination nanoparticles - important step towards effective mucosal vaccines
|Journal of Controlled Release|2016|127
Viral discovery and diversity in trypanosomatid protozoa with a focus on relatives of the human parasite <i>Leishmania</i>
|Proceedings of the National Academy of Sciences|2017|109